These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11496335)

  • 1. Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis.
    Leung TW; Cheung AN; Cheng DK; Wong LC; Ngan HY
    Oncol Rep; 2001; 8(5):1159-64. PubMed ID: 11496335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
    Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
    Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
    Sato S; Ito K; Ozawa N; Yajima A; Sasano H
    Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma.
    Tateishi M; Ishida T; Kohdono S; Hamatake M; Fukuyama Y; Sugimachi K
    Surg Oncol; 1994 Apr; 3(2):109-13. PubMed ID: 7952390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of epidermal growth factor receptor in carcinoma of the cervix.
    Kim JW; Kim YT; Kim DK; Song CH; Lee JW
    Gynecol Oncol; 1996 Feb; 60(2):283-7. PubMed ID: 8631552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-1 correlates with poor prognosis in lung adenocarcinoma.
    Sun BS; Yao YQ; Pei BX; Zhang ZF; Wang CL
    Thorac Cancer; 2016 Sep; 7(5):556-563. PubMed ID: 27766775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
    Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C
    Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
    van Dam PA; Vergote IB; Lowe DG; Watson JV; van Damme P; van der Auwera JC; Shepherd JH
    J Clin Pathol; 1994 Oct; 47(10):914-9. PubMed ID: 7962604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
    Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
    Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
    PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
    Zhang L; Yuan SZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
    Guddo F; Giatromanolaki A; Koukourakis MI; Reina C; Vignola AM; Chlouverakis G; Hilkens J; Gatter KC; Harris AL; Bonsignore G
    J Clin Pathol; 1998 Sep; 51(9):667-71. PubMed ID: 9930070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
    Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
    Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
    Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
    Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.